The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Na-v 1.6 Article

Hossain, Muhammad M, Weig, Blair, Reuhl, Kenneth et al. (2018). The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Na-v 1.6 . EXPERIMENTAL NEUROLOGY, 308 111-119. 10.1016/j.expneurol.2018.07.005

Open Access

cited authors

  • Hossain, Muhammad M; Weig, Blair; Reuhl, Kenneth; Gearing, Marla; Wu, Long-Jun; Richardson, Jason R

sustainable development goals

authors

publication date

  • October 1, 2018

published in

keywords

  • ACTIVATION
  • ALZHEIMERS-DISEASE
  • ANTIEPILEPTIC DRUG
  • EXPRESSION
  • GATED SODIUM-CHANNELS
  • IN-VIVO
  • Life Sciences & Biomedicine
  • MODEL
  • MPTP
  • MPTP-INDUCED NEUROINFLAMMATION
  • Microglia
  • NERVOUS-SYSTEM
  • Na(v)1.6
  • Neuroinflammation
  • Neurosciences
  • Neurosciences & Neurology
  • OXIDATIVE STRESS
  • Parkinson's disease
  • Science & Technology
  • TNF-alpha
  • Voltage-gated sodium channels
  • Zonisamide
  • gp91(phox)

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 111

end page

  • 119

volume

  • 308